KPMG, Others Expect India State Of Gujarat To Be Global Center Of Generics, R&D (India)
This article was originally published in PharmAsia News
The financial advisory company KPMG said in a report the Indian state of Gujarat stands to become the global center for generic drugs, research and development and manufacturing services. The state already has attracted several pharmaceutical companies expected to be leaders in generics, according to one health care CEO, becoming the center of growth for pharmas of all types. A government official said he expected the future of Gujarat to lie in biotechnology and nanotechnology, which in turn are likely to have an influence on the pharma industry. (Click here for more
You may also be interested in...
This month’s column covers deals announced between 1-23 April 2020.
EU MDR Panel Discussion: Why An Extra Year Is Not Really A Delay For The MDR - How To Survive Changing And Confusing Times
May 26 2020, the date that the Medical Device Regulation was originally due to apply in the EU, was a good time to take stock of where the medtech sector finds itself. Three of the most renowned and outspoken experts on the EU medical device regulatory system gave their views in this exclusive interview.
Multiple vaccine and drug developers across the world report progress and partnerships amid volatility in their shares.